DarioHealth Corp.
- DRIO
- NASDAQ
- Medical - Specialties
- Digital Therapeutics
- Metabolic Health (Diabetes/Hypertension)
$4.49
Today −6.85%Quote Oct 19, 2026, 08:00 PM UTC
−37.64%over the last month
Max drawdown −37.6%From 1-month high −37.6%3 months −35.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About DarioHealth
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management.
Sector
Healthcare
Industry
Medical - Specialties
Exchange
NASDAQ
Employees
163
Founded
2011
Market value
$44.0M
Quote Oct 19
Floor
$4.30
4.2% below price
Resistance
$5.34
18.9% above price
Price vs analyst targets
9 analysts
Lowest target
$7.50Highest target
$16.00
$7.50Highest target
$16.00
- Price $4.49
- Average target $12.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 178% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DRIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free